Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (5): 50-53.doi: 10.6040/j.issn.1673-3770.0.2022.433

• Original Article • Previous Articles     Next Articles

Diagnostic utility of folate receptor-positive circulating tumor cells in patients with laryngeal squamous cell carcinoma

ZHANG Zhuping, YE Qi, GUO Bei, LIN Ling   

  1. Department of Otolaryngology Head and Neck Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China
  • Published:2023-10-13

PDF (PC)

130

Abstract: Objective To determine serum levels of folate receptor-positive circulating tumor cells(FR+-CTCs)in patients with laryngeal squamous cell carcinoma(LSCC)and investigate its utility in the diagnosis of LSCC. Methods Forty-two patients with LSCC and 22 with benign laryngeal lesions admitted to the authors’ hospital were enrolled in this study. The significance of peripheral blood levels of FR+-CTCs, combined with clinical characteristics, in the diagnosis of LSCC was analyzed. Results FR+-CTC levels in patients with LSCC were higher than those in the benign group(t=7.269, P<0.001). Additionally, FR+-CTC level was associated with clinical stage, T stage, and differentiation grade(P<0.05), but not with sex, age, location, smoking, or lymph node metastasis(P>0.05). The area under the receiver operating characteristic curve was 0.857; sensitivity was 76.2% and specificity was 95.5% for the detection of LSCC with 9.0 FU/3 mL as the cut-off value. Conclusion Peripheral blood levels of FR+-CTCs in patients with LSCC were increased and was associated with clinical stage and differentiation grade. The determination of FR+-CTC levels is anticipated to be applied in the clinical diagnosis of LSCC.

Key words: Laryngeal cancer, Folate receptor, Circulating tumor cell, Serum, Biomarkers

CLC Number: 

  • R739.6
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: a cancer journal for clinicians, 2018, 68(6): 394-424. doi: 10.3410/f.734004835.793587632
[2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA A Cancer J Clin, 2016, 66(1): 7-30. doi:10.3322/caac.21332
[3] Tinhofer I, Staudte S. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook[J]. Expert Rev Mol Diagn, 2018, 18(10): 897-906. doi:10.1080/14737159.2018.1522251
[4] He W, Kularatne SA, Kalli KR, et al. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands[J]. Int J Cancer, 2008, 123(8): 1968-1973. doi:10.1002/ijc.23717
[5] 汪莹, 申复进, 郑红云, 等. 叶酸受体阳性循环肿瘤细胞在卵巢癌辅助诊断和疗效监测中的应用价值[J]. 实用临床医药杂志, 2022, 26(13): 79-83, 92. doi:10.7619/jcmp.20220206 WANG Ying, SHEN Fujin, ZHENG Hongyun, et al. Application value of folate receptor-positive circulating tumor cells in auxiliary diagnosis and therapeutic effect monitoring of ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 79-83, 92. doi:10.7619/jcmp.20220206
[6] Yan S, Guo WY, Liu YL, et al. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study[J]. Int J Clin Oncol, 2022, 27(3): 538-544. doi:10.1007/s10147-021-02097-2
[7] Li Z, Xu K, Xu LK, et al. Predictive value of folate receptor-positive circulating tumor cells for the preoperative diagnosis of lymph node metastasis in patients with lung adenocarcinoma[J]. Small Methods, 2021, 5(6): e2100152. doi:10.1002/smtd.202100152
[8] Yu Y, Chen ZL, Dong JS, et al. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer[J]. Transl Oncol, 2013, 6(6): 697-702. doi:10.1593/tlo.13535
[9] Kong LY, Birkeland AC. Liquid biopsies in head and neck cancer: current state and future challenges[J]. Cancers(Basel), 2021, 13(8): 1874. doi:10.3390/cancers13081874
[10] 刘坤, 张欣欣. 循环肿瘤细胞在头颈部鳞癌中的富集及检测[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 18-24. doi:10.6040/j.issn.1673-3770.1.2019.039 LIU Kun, ZHANG Xinxin. Progress in clinical research on circulating tumor cells in squamous cell carcinoma of the head and neck[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 18-24. doi:10.6040/j.issn.1673-3770.1.2019.039
[11] 李倩, 郑琪, 马婕群, 等. 叶酸受体阳性循环肿瘤细胞检测的临床研究进展[J]. 标记免疫分析与临床, 2020, 27(2): 356-360. doi:10.11748/bjmy.issn.1006-1703.2020.02.036 LI Qian, ZHENG Qi, MA Jiequn, et al. The progress of clinical research on folate receptor-positive circulating tumor cells analysis[J]. Labeled Immunoassays and Clinical Medicine, 2020, 27(2): 356-360. doi:10.11748/bjmy.issn.1006-1703.2020.02.036
[12] Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions[J]. J Clin Invest, 2009, 119(6): 1429-1437. doi:10.1172/JCI36183
[13] Li Z, Xu K, Xu LK, et al. Predictive value of folate receptor-positive circulating tumor cells for the preoperative diagnosis of lymph node metastasis in patients with lung adenocarcinoma[J]. Small Methods, 2021, 5(6): e2100152. doi:10.1002/smtd.202100152
[14] Wu Q, Zheng HY, Gu J, et al. Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer[J]. J Clin Lab Anal, 2022, 36(1): e24180. doi:10.1002/jcla.24180
[15] Lian SY, Yang LJ, Feng Q, et al. Folate-receptor positive circulating tumor cell is a potential diagnostic marker of prostate cancer[J]. Front Oncol, 2021, 11: 708214. doi:10.3389/fonc.2021.708214
[16] Yan S, Guo WY, Liu YL, et al. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study[J]. Int J Clin Oncol, 2022, 27(3): 538-544. doi:10.1007/s10147-021-02097-2
[17] Wu XL, Tu Q, Faure G, et al. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis[J]. Sci Rep, 2016, 6: 20210. doi:10.1038/srep20210
[18] Rizzo MI, Ralli M, Nicolazzo C, et al. Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: comparative pre- and post-operative analysis and association with prognosis[J]. Oncol Lett, 2020, 19(6): 4183-4188. doi:10.3892/ol.2020.11528
[19] 陈燕. 叶酸受体在鼻咽癌、喉癌中的表达及临床意义[D]. 重庆: 重庆医科大学, 2007
[1] ZHANG Xi, DENG Qicheng, ZHANG Zhen, CHEN Yao, WANG Jingsong, ZHAO Rui, LIU Hai. Effect of nutritional support on postoperative pharyngeal fistula after laryngeal cancer surgery: a Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 51-59.
[2] XU Chong, WANG Xiaoting, YI Hongliang. Single-cell sequencing analysis of laryngeal cancer and its microenvironmental metabolism-related target genes [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 33-38.
[3] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
[4] WANG MeiOverview,LI ZhihaiGuidance. Laryngeal cancer stem cells: potential therapeutic targets for overcoming multidrug resistance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 120-128.
[5] WANG Xiaoting, CHEN Zhengnong, YI Hongliang. Transcriptomic analysis of glutamine deprivation on laryngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 26-31.
[6] LI Yanjie, JIA Jian, YANG Ping, WAN Baoluo. Study on the value of tumor abnormal protein in clinical diagnosis of laryngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 70-74.
[7] LI Jianzhong, ZHOU Yongrui, LI Huiying, LI Miaobian, SUN Yidi, QIU Qianhui. A study of low-temperature plasma ablation for the treatment of benign thyroid nodules under ultrasound guidance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(2): 34-38.
[8] ZHANG Yiyi,XUE Gang, JIN Chunting. Research progress of exosomes in thyroid cancers [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(2): 131-135.
[9] ZENG Bo, TIAN Xingde. Relationship between serum procalcitonin level of tumor-bearing mice and medullary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 86-91.
[10] LI Wenjing,LIU Ming. Research progress on the relationship between the C2H2 zinc finger protein family and laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 125-130.
[11] . The swallowing function recovery study on tongue flap after horizontal hemilaryngectomy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 127-131.
[12] Lu LUO,En ZHOU,Si OUYANG,Yi CHEN,Xuping XIAO,Jihua WANG. Expression of the microRNA let-7a in the serum of 42 patients with laryngeal cancer and its significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 96-100.
[13] Kun LIU,Xinxin ZHANG. Progress in clinical research on circulating tumor cells in squamous cell carcinoma of the head and neck [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 18-24.
[14] ZOU Liangyu, LI Lianhe, YUE Wenhui, HAN Zhipeng, ZHANG Zihui. Clinical significance and correlation between MIF and GSK-3β expression in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 76-80.
[15] PU Hongbo, DU Xiaodong. Allergen test results in 2 000 patients with allergic rhinitis in Wuxi District [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 105-107.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd